Pfizer project is quality-by-design milestone for FDA and EMA | qbd |
A pilot project set up earlier this year to encourage the adoption of quality-by-design in pharmaceutical manufacturing has passed its first milestone, with the first parallel application now filed with regulators on both sides of the Atlantic.

Quality-by-design (QbD) is a concept in which the quality aspects of a production process and the resulting product are intended to be built-in from the start, based on a clear understanding of the process and the use of a well-defined risk-management strategy.
Via Thibaud Guymard